Petra Åhl

Title: Innovations by Petra Åhl in Dialysis Therapy

Introduction

Petra Åhl is a notable inventor based in Gällivare, Sweden. She has made significant contributions to the field of dialysis therapy through her innovative patents. With a total of three patents to her name, Åhl's work focuses on improving anticoagulation systems used in medical treatments.

Latest Patents

Petra Åhl's latest patents include a multipart fluid system and a system for regional citrate anticoagulation with a phosphate comprising anticoagulation fluid. The multipart fluid system is designed for dialysis therapy and includes an anticoagulation fluid along with at least one treatment fluid, which can be dialysis fluid or infusion fluids. The anticoagulation fluid in this system comprises 10-40 mM citrate and 0.1-2.0 mM phosphate. The treatment fluid is formulated to contain 0-5 mM total calcium, 0-8 mM citrate, and 0.1-2.0 mM phosphate, with specific conditions regarding the presence of citrate and calcium. Additionally, her invention addresses a system for regional citrate anticoagulation in an extracorporeal blood circuit, enhancing the safety and efficacy of dialysis procedures.

Career Highlights

Petra Åhl is associated with Gambro Lundia AB, a company known for its advancements in dialysis technology. Her work has been instrumental in developing innovative solutions that improve patient outcomes in dialysis therapy.

Collaborations

Petra Åhl has collaborated with notable colleagues, including Anders Wieslander and Gabriela Godaly. These partnerships have contributed to the successful development of her patented technologies.

Conclusion

Petra Åhl's contributions to dialysis therapy through her innovative patents demonstrate her commitment to advancing medical technology. Her work continues to impact the field positively, enhancing treatment options for patients in need.